Cargando…
Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis
BACKGROUND: The COVID-19 pandemic outbreak raises the question of whether immunization is recommended for patients with CNS demyelinating diseases. On the one hand, existing studies suggested that SARS-CoV-2 vaccinations are not associated with increased risk of relapse activity. On the other hand,...
Autores principales: | Kong, Lingyao, Wang, Xiaofei, Chen, Hongxi, Shi, Ziyan, Lang, Yanlin, Zhang, Ying, Zhou, Hongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472679/ https://www.ncbi.nlm.nih.gov/pubmed/36170773 http://dx.doi.org/10.1016/j.msard.2022.104167 |
Ejemplares similares
-
Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder
por: Kong, Lingyao, et al.
Publicado: (2022) -
Effects of pregnancy on neuromyelitis optica spectrum disorder and predictors of related attacks
por: Du, Qin, et al.
Publicado: (2022) -
The causal relationship between neuromyelitis optica spectrum disorder and other autoimmune diseases
por: Wang, Xiaofei, et al.
Publicado: (2022) -
Initial BMI effects on clinical presentation and prognosis in neuromyelitis optica spectrum disorder
por: Luo, Wenqin, et al.
Publicado: (2023) -
Visual disability in neuromyelitis optica spectrum disorders: prognostic prediction models
por: Luo, Wenqin, et al.
Publicado: (2023)